Friday, 4 June 2021

Zydus Cadila receives tentative approval from USFDA for Osimertinib Tablets

Zydus Cadila receives tentative approval from USFDA for Osimertinib Tablets
Zydus Cadila receives tentative approval from USFDA for Osimertinib Tablets

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs nearly 25000 people worldwide and is dedicated to creating healthier communities globally.

admin Fri, 06/04/2021 - 15:23

source https://www.pharmatutor.org/pharma-news/2021/zydus-cadila-receives-tentative-approval-from-usfda-for-osimertinib-tablets

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...